Literature DB >> 17634265

Fructan supplementation and infection affect food intake, fever, and epithelial sloughing from Salmonella challenge in weanling puppies.

Carolyn J Apanavicius1, Kristy L Powell, Brittany M Vester, Lisa K Karr-Lilienthal, Lynda L Pope, Nathan D Fastinger, Matthew A Wallig, Kelly A Tappenden, Kelly S Swanson.   

Abstract

Our objective was to examine the effects of fructan supplementation on the immune response of weanling puppies subjected to bacterial challenge. Previous studies in bacterial challenged neonatal piglets have reported benefits of fructan supplementation. Thirty hound-cross puppies (12 wk of age) were used in a 2 x 3 factorial randomized complete block design. Following a 7-d baseline period, puppies were assigned to diets containing: 1) no prebiotic, 2) 1% short-chain fructooligosaccharides (scFOS), or 3) 1% inulin. After 14 d on treatment diet, dogs received an oral gavage of: 1) Salmonella typhimurium DT104 (5 x 10(8) colony forming units) or 2) 0.9% saline. Food intake, fecal and activity scores, body temperature, body weight, blood chemistry, intestinal nutrient transport, intestinal morphology and pathology, and gut microbiota were measured. Food intake decreased (P < 0.01) and body temperature increased (P < 0.05) in infected puppies. However, the decrease in food intake was less (P < 0.05) in those consuming fructans. Infected puppies consuming fructans also had decreased (P = 0.05) severity of enterocyte sloughing than those fed the control diet. Ileal Na+-dependent glucose transport was decreased (P = 0.02) in infected vs. noninfected puppies consuming CON, whereas no changes occurred in fructan-supplemented animals. Puppies consuming inulin also had increased fecal acetate (P = 0.03) and total short-chain fatty acid (P = 0.06) concentrations than scFOS-fed puppies and controls. Finally, puppies fed inulin had an increase (P = 0.05) in Lactobacillus concentrations compared with scFOS and CON. In summary, fructan supplementation appeared to attenuate some of the negative responses associated with Salmonella challenge and may provide protection against infection in weanling puppies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634265     DOI: 10.1093/jn/137.8.1923

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  5 in total

Review 1.  Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.

Authors:  Glenn R Gibson; Robert Hutkins; Mary Ellen Sanders; Susan L Prescott; Raylene A Reimer; Seppo J Salminen; Karen Scott; Catherine Stanton; Kelly S Swanson; Patrice D Cani; Kristin Verbeke; Gregor Reid
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-14       Impact factor: 46.802

2.  A genomic island of an extraintestinal pathogenic Escherichia coli Strain enables the metabolism of fructooligosaccharides, which improves intestinal colonization.

Authors:  Catherine Schouler; Ahmed Taki; Iman Chouikha; Maryvonne Moulin-Schouleur; Philippe Gilot
Journal:  J Bacteriol       Date:  2008-10-31       Impact factor: 3.490

Review 3.  Implication of fructans in health: immunomodulatory and antioxidant mechanisms.

Authors:  Elena Franco-Robles; Mercedes G López
Journal:  ScientificWorldJournal       Date:  2015-03-16

4.  A diet change from dry food to beef induces reversible changes on the faecal microbiota in healthy, adult client-owned dogs.

Authors:  Kristin M V Herstad; Karina Gajardo; Anne Marie Bakke; Lars Moe; Jane Ludvigsen; Knut Rudi; Ida Rud; Monika Sekelja; Ellen Skancke
Journal:  BMC Vet Res       Date:  2017-05-30       Impact factor: 2.741

5.  Effects of Supplemental Mannanoligosaccharides on Growth Performance, Faecal Characteristics and Health in Dairy Calves.

Authors:  Cagdas Kara; Huseyin Cihan; Mutlu Temizel; Serkan Catik; Yavuz Meral; Abdulkadir Orman; Artun Yibar; Hidir Gencoglu
Journal:  Asian-Australas J Anim Sci       Date:  2015-11       Impact factor: 2.509

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.